Table 2 Study measures
| Â | (N = 20) | Â |
|---|---|---|
| Â | n | (%) |
1. Was the study valid? | Â | Â |
Yes | 15 | (75) |
No | 5 | (25) |
2. Was the study funded by a pharmaceutical company? | Â | Â |
Yes | 16 | (80) |
No | 1 | (5) |
Unknown | 3 | (15) |
3. What was the study outcome? | Â | Â |
Patient-oriented | 12 | (60) |
Disease-oriented | 8 | (40) |
4. What was the study therapy compared to? | Â | Â |
Another medication or therapy | 8 | (40) |
Placebo | 10 | (50) |
Neither | 2 | (10) |
5. Was a graphic* used on the brochure? | Â | Â |
Yes | 19 | (95) |
No | 1 | (5) |
6. Of the brochures with graphics, how was the data presented? | Â | Â |
Relative risk reduction | 4 | (21) |
Absolute risk reduction | 1 | (5) |
Other** | 14 | (74) |
7. Was the outcome of interest statistically significant?*** | Â | Â |
Yes | 19 | (95) |
No | 1 | (5) |
8. Did the data on the brochure differ from the underlying study? | Â | Â |
Yes | 3 | (15) |
No | 17 | (85) |